---
title: "CTXR.US (CTXR.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CTXR.US/news.md"
symbol: "CTXR.US"
name: "CTXR.US"
parent: "https://longbridge.com/en/quote/CTXR.US.md"
datetime: "2026-05-21T19:27:47.608Z"
locales:
  - [en](https://longbridge.com/en/quote/CTXR.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CTXR.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CTXR.US/news.md)
---

# CTXR.US (CTXR.US) — Related News

### [12 Health Care Stocks Moving In Monday's Pre-Market Session](https://longbridge.com/en/news/286769314.md)
*2026-05-18T12:05:40.000Z*
> In Monday's pre-market session, Sunshine Biopharma surged 635.6% to $2.09, while Geovax Labs rose 169.91% to $3.32. Othe

### [16:30 ETCitius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update](https://longbridge.com/en/news/286611505.md)
*2026-05-15T20:34:07.000Z*
> Citius Pharmaceuticals, Inc. reported $5.6 million in net revenue for the first half of fiscal 2026, driven by the launc

### [Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update | CTOR Stock News](https://longbridge.com/en/news/286611095.md)
*2026-05-15T12:30:42.000Z*
> Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update | CTOR Stock New

### [Citius Pharmaceuticals Amends Promissory Note to Enhance Flexibility](https://longbridge.com/en/news/285780539.md)
*2026-05-08T22:05:15.000Z*
> Citius Pharmaceuticals has amended a $3.8 million promissory note to enhance flexibility. The repayment is now deferred 

### [Citius raises $36.5m for Lymphir commercialisation](https://longbridge.com/en/news/285400494.md)
*2026-05-06T12:04:52.000Z*
> A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings.

### [Citius Pharmaceuticals Raises ~$5M; Issues Warrants in Registered Direct and Private Placement](https://longbridge.com/en/news/284054908.md)
*2026-04-24T21:03:00.000Z*
> Citius Pharmaceuticals raised approximately $5 million through a registered direct offering and private placement with i

### [Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules | CTXR Stock News](https://longbridge.com/en/news/283997055.md)
*2026-04-24T04:01:01.000Z*
> Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules | CT